-
ID
Bron
Verkorte titel
Aandoening
supplementation of vitamins and fish oil fatty acids during pregnancy and lactation
breast milk
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
the primary aim of the study is to find the dose of DHA during pregnancy and lactation that leads to a mean breast milk DHA of at least 0.7g%
Achtergrond van het onderzoek
-
Doel van het onderzoek
-
Onderzoeksopzet
the first time point is at the start of the study at week 20 in the pregnancy.
The second time point (compliance) is week 36 of the pregnancy
The third time point and end point is 4 weeks after the delivery
Onderzoeksproduct en/of interventie
fish oil- fatty acids
vitamin D
multivitamin
Publiek
Eline Stoutjesdijk;
UMCG hanzeplein 1
Groningen 9700 RB
The Netherlands
+31503610399
e.stoutjesdijk@umcg.nl
Wetenschappelijk
Eline Stoutjesdijk;
UMCG hanzeplein 1
Groningen 9700 RB
The Netherlands
+31503610399
e.stoutjesdijk@umcg.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Change in inclusion criteria 26-06-2017:
apparently healthy women, during a non-complicated single pregnancy
BMI between 18 and 29 kg/m2 before pregnancy
good control of the Dutch language
willing to stop taking multivitamins, folic acid, vitamin D and fish oil supplements if taken
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
hyperemesis graviradum
vegetarian or vegan
diabetes mellitus
criteria for individual ending of the study
preterm birth (gestational age less than 37 weeks) and birth after 42 weeks
complications mother
pregnancy diabetes
pre-eclampsia, placental insufficiency, intrauterine growth retardation
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiƫnten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4835 |
NTR-old | NTR4959 |
CCMO | NL49639.042.14 |
OMON | NL-OMON41801 |